Rusan Pharma secures PMDA GMP approval for Ankleshwar and Dehradun facilities
Approval from Japan regulator covers API and finished dosage manufacturing units
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lupin subsidiary enters settlement agreement with Humana in US antitrust litigation
Lupin Pharmaceuticals Inc to pay USD 30 million under agreement without admission of liability
Aurobindo Pharma secures USFDA approval for Glycerol Phenylbutyrate Oral Liquid
Company to launch product for urea cycle disorders with market size of US$ 50.2 million
Alembic Pharma gets USFDA nod for Methotrexate Injection USP, 50 mg/2 mL multi-dose vials and 1g/40…
Methotrexate Injection is a folate analog metabolic inhibitor indicated for neoplastic diseases
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
The shift reflects intensifying demand for metabolic therapies and growing logistics risk, signaling a structural move toward…
Rubicon Research acquires 85% stake in Arinna Lifesciences
Transaction valued at INR 200 crore to expand presence in CNS therapies and domestic formulations market
Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India
New pricing for weight management drug effective from April 3, 2026
Aurigene and Alveus Therapeutics advance collaboration with ALV-200 candidate nomination
Partnership supports drug discovery programmes for obesity and metabolic disease
MSN Laboratories launches SEMABEST semaglutide in India after CDSCO approval
Product priced lower than innovator drug and introduced for type 2 diabetes treatment
Sun Pharma launches brand film with Royal Challengers Bengaluru
Campaign highlights association as principal sponsor and health partner during T20 season
Orbicular, Gland Pharma and Apotex secure US FDA approval for generic INFUVITE ADULT injectable
ANDA approval with CGT designation grants six-month exclusivity for parenteral nutrition product in the United States
Novo Nordisk announces partnership with OpenAI
Partnership applies AI to drug discovery and operations across Novo Nordisk and OpenAI programmes
Aragen launches ChemiSHE, India’s first women-led chemistry synthesis laboratory
Announces strategic diversity initiative to add 800 - 1,000 women employees across scientific and leadership roles over the next…
India Pharma 2026 highlights policy push, innovation driving sectoral growth
India is poised to lead the global pharma landscape with a focus on biosimilars and specialty medicines stressed J.P. Nadda, Union…
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
GlobalData highlights shift towards localised manufacturing, inventory security, and diversified supply networks to address rising…
Merck signs MoU with MAHE to expand healthcare R&D talent development in India
Catalyst training programme launched to link academic learning with industry requirements
The GLP-1 revolution
A new class of drugs is reshaping global health,but India’s generics wave could change who benefits. Dr Rajpushpa Labh,Consultant…
India brings together a rare and powerful combination of capabilities
Dr Kshitij Panse,Chief Operation Officer,GATINN by Servier,in an interaction with Kalyani Sharma, discusses the strategic…
Foundayo, Lilly’s new oral GLP-1 pill for weight loss, now available in US
Eli Lilly and Company announced that Foundayo (orforglipron) is now available to adults with obesity or overweight with…
OPPI collaborates with NIPER Rae Bareli to advance research excellence
The Organisation of Pharmaceutical Producers of India (OPPI) has announced a strategic collaboration with the National Institute…